These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33058859)

  • 21. Characteristics and Outcomes of Children With Conversion Disorder Admitted to a Single Inpatient Rehabilitation Unit, A Retrospective Study.
    Bolger A; Collins A; Michels M; Pruitt D
    PM R; 2018 Sep; 10(9):910-916. PubMed ID: 29550412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatic treatment of children with anti-NMDAR encephalitis.
    Mohammad SS; Jones H; Hong M; Nosadini M; Sharpe C; Pillai SC; Brilot F; Dale RC
    Dev Med Child Neurol; 2016 Apr; 58(4):376-84. PubMed ID: 26330176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sleep Characteristics in Pediatric Anti-
    Gombolay G; Morris M; Loerinc L; Blackwell L; Howarth R
    J Child Neurol; 2023 Apr; 38(5):298-306. PubMed ID: 37203168
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical manifestations, treatment outcomes, and prognostic factors of pediatric anti-NMDAR encephalitis in tertiary care hospitals: A multicenter retrospective/prospective cohort study.
    Pruetarat N; Netbaramee W; Pattharathitikul S; Veeravigrom M
    Brain Dev; 2019 May; 41(5):436-442. PubMed ID: 30639077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric anti-NMDA (N-methyl D-aspartate) receptor encephalitis.
    Salvucci A; Devine IM; Hammond D; Sheth RD
    Pediatr Neurol; 2014 May; 50(5):507-10. PubMed ID: 24656207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended Clinical Spectrum of Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Children: A Case Series.
    Goenka A; Jain V; Nariai H; Spiro A; Steinschneider M
    Pediatr Neurol; 2017 Jul; 72():51-55. PubMed ID: 28506503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric Anti-NMDA-R Encephalitis: Presentation, Diagnosis, and Management.
    Gerstle K; Hur MH; Moussa T
    Pediatr Ann; 2019 Oct; 48(10):e387-e390. PubMed ID: 31609996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Younger Age at Onset Is Associated With Worse Long-term Behavioral Outcomes in Anti-NMDA Receptor Encephalitis.
    Yeshokumar A; Gordon-Lipkin E; Arenivas A; Rosenfeld M; Patterson K; Blum R; Banwell B; Venkatesan A; Lancaster E; Panzer J; Probasco J
    Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35794025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agitation Management in Pediatric Males with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
    Schumacher LT; Mann AP; MacKenzie JG
    J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):939-943. PubMed ID: 27992257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of developmental versus functional assessment in the rehabilitation of young children.
    Long CE; Blackman JA; Farrell WJ; Smolkin ME; Conaway MR
    Pediatr Rehabil; 2005; 8(2):156-61. PubMed ID: 16089256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes.
    Wang Y; Zhang W; Yin J; Lu Q; Yin F; He F; Peng J
    J Neuroimmunol; 2017 Nov; 312():59-65. PubMed ID: 28935354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical presentation of anti-N-methyl-D-aspartate receptor encephalitis: two case reports.
    Maggio MC; Mastrangelo G; Skabar A; Ventura A; Carrozzi M; Santangelo G; Vanadia F; Corsello G; Cimaz R
    J Med Case Rep; 2017 Aug; 11(1):225. PubMed ID: 28810906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics, treatments, and outcomes of patients with anti-N-methyl-d-aspartate receptor encephalitis: A systematic review of reported cases.
    Zhang L; Wu MQ; Hao ZL; Chiang SM; Shuang K; Lin MT; Chi XS; Fang JJ; Zhou D; Li JM
    Epilepsy Behav; 2017 Mar; 68():57-65. PubMed ID: 28109991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics of anti
    Zheng J; Shen J; Wang A; Liu L; Xiong J; Li X; Xiao Y; Li J; Mao D; Liu L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 45(1):47-54. PubMed ID: 32132297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term rehabilitation management and outcome of anti-NMDA receptor encephalitis: case reports.
    Bach LJ
    NeuroRehabilitation; 2014; 35(4):863-75. PubMed ID: 25323083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approach to the Management of Pediatric-Onset Anti-N-Methyl-d-Aspartate (Anti-NMDA) Receptor Encephalitis: A Case Series.
    Brenton JN; Kim J; Schwartz RH
    J Child Neurol; 2016 Aug; 31(9):1150-5. PubMed ID: 27121044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
    Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
    Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival Analysis of Immunotherapy Effects on Relapse Rate in Pediatric and Adult Autoimmune Encephalitis.
    Yang JH; Liu EN; Nguyen L; Dunn-Pirio A; Graves JS
    Neurology; 2023 Nov; 101(22):e2300-e2313. PubMed ID: 37827848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes of pediatric Anti-NMDA receptor encephalitis.
    Shim Y; Kim SY; Kim H; Hwang H; Chae JH; Choi J; Kim KJ; Yum MS; Ko TS; Kim YO; Byeon JH; Lee J; Lee J; Kim JS; Lim BC
    Eur J Paediatr Neurol; 2020 Nov; 29():87-91. PubMed ID: 33046392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis.
    Nosadini M; Thomas T; Eyre M; Anlar B; Armangue T; Benseler SM; Cellucci T; Deiva K; Gallentine W; Gombolay G; Gorman MP; Hacohen Y; Jiang Y; Lim BC; Muscal E; Ndondo A; Neuteboom R; Rostásy K; Sakuma H; Sharma S; Tenembaum SN; Van Mater HA; Wells E; Wickstrom R; Yeshokumar AK; Irani SR; Dalmau J; Lim M; Dale RC
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34301820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.